Future Outlook: High-Throughput Small Animal Imaging
Small Animal Imaging is moving toward high-throughput systems that allow rapid, automated imaging of large cohorts of animals. High-throughput platforms integrate robotics, AI-assisted analysis, and multimodal imaging to streamline preclinical research and accelerate drug discovery.
Automation reduces variability and increases reproducibility, while AI algorithms extract quantitative metrics for organ volumes, tumor growth, metabolic activity, and biomarker expression. This enables researchers to evaluate multiple compounds, dosing regimens, or therapeutic strategies in a shorter timeframe.
High-throughput imaging supports longitudinal studies, enabling repeated measurements in the same animals, reducing total animal usage and increasing the statistical power of experiments. As the technology matures, high-throughput small animal imaging will become a standard in pharmaceutical and academic research, bridging the gap between preclinical studies and clinical translation.